Physician profile
Lee Michals
NPI 1154687754
$1,029.75
in general payments reported to CMS, 2019-2025
8 companies · $35.71 in 2025
The $35.71 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $92.88 · 2022: $62.06 · 2023: $263 · 2024: $63.38 · 2025: $35.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $279.33 | 2019-2025 | Aristada, Lybalvi, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $223.88 | 2019-2023 | Rexulti |
| Indivior INC. | $159.94 | 2019-2024 | Sublocade |
| Gilead Sciences, INC. | $143.19 | 2022-2023 | Epclusa |
| Sunovion Pharmaceuticals INC. | $110.79 | 2019 | |
| Braeburn INC. | $56.11 | 2023-2025 | Brixadi |
| Teva Pharmaceuticals USA, INC. | $39.23 | 2020 | |
| Neurocrine Biosciences, INC. | $17.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Michals listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.